MEANINGFUL REDUCTION OF HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH CHRONIC HEPATITIS C WHO RECEIVED PEGILE INTERFERON PLUS RIBAVIRIN THERAPY TWO TERTIARY CENTER EXPERIENCE


sirin g., ŞENTÜRK Ö., ÇELEBİ A. , YILMAZ H., sezikli m., HÜLAGÜ S.

23 rd United European Gastroenterology Week, 24 - 28 October 2015

  • Publication Type: Conference Paper / Summary Text